Drug and Alcohol Rehabilitation: Vixapatin (VP12), a C-Type Lectin-Protein From Vipera Xantina Palestinae Venom: Characterization as a Novel Anti-Angiogenic Compound.
Vixapatin (VP12), a C-Type Lectin-Protein from Vipera xantina palestinae Venom: Characterization as a Novel Anti-angiogenic Compound.
Filed under: Drug and Alcohol Rehabilitation
Toxins (Basel). 2012 Oct; 4(10): 862-77
Momic T, Cohen G, Reich R, Arlinghaus FT, Eble JA, Marcinkiewicz… Continue reading
[Pharmacodynamic Study of Racemic TJ0711 on Renal Hypertensive Rats After Long-Term Administration].
[Pharmacodynamic study of racemic TJ0711 on renal hypertensive rats after long-term administration].
Filed under: Drug and Alcohol Rehabilitation
Yao Xue Xue Bao. 2012 Aug; 47(8): 1001-5
Li RJ, Qiu J, Zhang XN, Chen J, Li G
The study is… Continue reading
Drug Rehab Center | Holistic Healing | MoonviewSanctuary.com
Drug Rehab Center | Holistic Healing | MoonviewSanctuary.com – Moonview Sanctuary is a non-residential treatment and optimal performance center for individuals who are challenged by emotional, physical, social or spiritual upheavals. MoonView specializes in combining Eastern and Western approaches… Continue reading
Drug and Alcohol Rehabilitation: The Utility of Tumor-Specifically Internalizing Peptides for Targeted siRNA Delivery Into Human Solid Tumors.
The Utility of Tumor-specifically Internalizing Peptides for Targeted siRNA Delivery into Human Solid Tumors.
Filed under: Drug and Alcohol Rehabilitation
Anticancer Res. 2012 Nov; 32(11): 4685-90
Un F, Zhou B, Yen Y
Ribonucleotide reductase composed of the hRRM1 and… Continue reading
Epistaxis Secondary to Panitumumab in a Patient With Colon Cancer.
Epistaxis secondary to panitumumab in a patient with colon cancer.
Filed under: Drug and Alcohol Rehabilitation
Anticancer Res. 2012 Nov; 32(11): 4983-5
Kornreich DA, Saif MW
Epidermal growth factor receptor inhibitors (EGFRIs) have become an integral part of therapy… Continue reading
Drug and Alcohol Rehabilitation: Galactosylated Chitosan/5-Fluorouracil Nanoparticles Inhibit Mouse Hepatic Cancer Growth and Its Side Effects.
Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
Filed under: Drug and Alcohol Rehabilitation
World J Gastroenterol. 2012 Nov 14; 18(42): 6076-87
Cheng MR, Li Q, Wan T, He B, Han J, Chen HX, Yang… Continue reading